|
|
|
|
|
|
|
|
|
|
|
|
|
|
Previous: LA JOLLA PHARMACEUTICAL CO, 10-Q, 2000-08-04 |
Next: LA JOLLA PHARMACEUTICAL CO, S-3, 2000-08-04 |
<TABLE> <S> <C>
<ARTICLE> 5
<MULTIPLIER> 1,000
<S> <C>
<PERIOD-TYPE> 6-MOS
<FISCAL-YEAR-END> DEC-31-2000
<PERIOD-START> JAN-01-2000
<PERIOD-END> JUN-30-2000
<CASH> 9,388
<SECURITIES> 8,960
<RECEIVABLES> 0
<ALLOWANCES> 0
<INVENTORY> 0
<CURRENT-ASSETS> 661
<PP&E> 4,514
<DEPRECIATION> (3,898)
<TOTAL-ASSETS> 21,257
<CURRENT-LIABILITIES> 1,347
<BONDS> 0
0
0
<COMMON> 245
<OTHER-SE> 19,665
<TOTAL-LIABILITY-AND-EQUITY> 21,257
<SALES> 0
<TOTAL-REVENUES> 0
<CGS> 0
<TOTAL-COSTS> 0
<OTHER-EXPENSES> 6,447
<LOSS-PROVISION> 0
<INTEREST-EXPENSE> 5
<INCOME-PRETAX> (5,871)
<INCOME-TAX> 0
<INCOME-CONTINUING> (5,871)
<DISCONTINUED> 0
<EXTRAORDINARY> 0
<CHANGES> 0
<NET-INCOME> (5,871)
<EPS-BASIC> (0.25)
<EPS-DILUTED> (0.25)
</TABLE>
|
|